Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.665
-0.005 (-0.14%)
Apr 28, 2026, 11:35 AM EDT - Market open
Prime Medicine Revenue
In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth. Prime Medicine had revenue of $838.00K in the quarter ending December 31, 2025, a decrease of -61.61%.
Revenue (ttm)
$4.63M
Revenue Growth
+55.28%
P/S Ratio
140.30
Revenue / Employee
$31,726
Employees
146
Market Cap
649.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.63M | 1.65M | 55.28% |
| Dec 31, 2024 | 2.98M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CorMedix | 311.71M |
| Arvinas | 262.60M |
| Gyre Therapeutics | 116.59M |
| Lexicon Pharmaceuticals | 49.80M |
| Prothena Corporation | 9.68M |
| Aclaris Therapeutics | 7.83M |
| Shattuck Labs | 1.00M |
PRME News
- 12 days ago - Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - Prime Medicine Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - Prime Medicine Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Prime Medicine Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease - GlobeNewsWire